NCT01843868 2024-08-07
Emesis Control Study in Non-Hodgkin Lymphoma Patients Receiving R-CHOP
Australasian Leukaemia and Lymphoma Group
Phase NA Withdrawn
Australasian Leukaemia and Lymphoma Group
GlaxoSmithKline
Duke University
University of Oklahoma